| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
group | 0.500 | strong | 0.987 | 2 | 0 | 1986 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
myocardin | 0.619 | 0.615 | 0.33 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
glucosidase alpha, acid | 0.631 | 0.577 | 2.8E-18 |
|
group | 0.360 | limited | 0.857 | 1 | 0 | 1994 | 2018 | ||||||||
|
myosin heavy chain 7 | 0.516 | 0.692 | 4.2E-16 |
|
group | 0.500 | strong | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
receptor accessory protein 1 | 0.653 | 0.423 | 0.99 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
solute carrier family 22 member 5 | 0.608 | 0.731 | 5.3E-16 |
|
group | 0.350 | limited | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
desmin | 0.460 | 0.846 | 8.8E-03 |
|
group | 0.600 | strong | 1.000 | 1 | 0 | 1992 | 2019 | ||||||||
|
LIM zinc finger domain containing 2 | 0.751 | 0.308 | 5.1E-05 |
|
group | 0.310 | limited | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
SOS Ras/Rac guanine nucleotide exchange factor 1 | 0.485 | 0.808 | 1.00 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
sarcoglycan delta | 0.641 | 0.615 | 2.1E-03 |
|
group | 0.580 | None | 0.900 | 0 | 0 | 1997 | 2015 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
group | 0.380 | None | 1.000 | 0 | 0 | 2008 | 2018 | ||||||||
|
ryanodine receptor 2 | 0.539 | 0.615 | 1.00 |
|
group | 0.440 | None | 1.000 | 0 | 0 | 2001 | 2017 | ||||||||
|
Ras like without CAAX 1 | 0.527 | 0.808 | 0.13 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2016 | 2016 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
GATA zinc finger domain containing 1 | 0.736 | 0.385 | 0.43 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
junctophilin 2 | 0.736 | 0.154 | 4.5E-05 |
|
group | 0.410 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
actin alpha cardiac muscle 1 | 0.610 | 0.538 | 0.74 |
|
group | 0.460 | None | 1.000 | 0 | 0 | 1999 | 2015 | ||||||||
|
tafazzin | 0.477 | 0.808 | 0.73 |
|
group | 0.500 | None | 1.000 | 0 | 0 | 2003 | 2020 | ||||||||
|
troponin C1, slow skeletal and cardiac type | 0.647 | 0.462 | 0.68 |
|
group | 0.350 | None | 1.000 | 0 | 0 | 2007 | 2019 | ||||||||
|
nexilin F-actin binding protein | 0.695 | 0.269 | 3.9E-11 |
|
group | 0.430 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
actinin alpha 2 | 0.686 | 0.462 | 1.00 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
caveolin 3 | 0.564 | 0.692 | 5.5E-03 |
|
group | 0.350 | None | 1.000 | 0 | 0 | 2003 | 2016 | ||||||||
|
titin-cap | 0.682 | 0.538 | 0.19 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 2004 | 2004 |